CONCLUSIONS	When used as adjuvant `` renal protective '' therapy in patients with HF with renal dysfunction , the recommended dose of nesiritide reduced blood pressure , did not seem to worsen renal function , and suppressed endothelin but did not enhance diuretic responsiveness or prevent activation of the renin-angiotensin-aldosterone system .\